Anatomy of the Biotech IPO: Legal and Strategic Lessons

Session details:

Taking a biotech company public is one of the most complex and high-stakes inflection points in its lifecycle, one that requires precision across legal, financial, and strategic domains. In this panel, legal and executive leaders will unpack the IPO process from both sides of the table, exploring what it takes to prepare, execute, and thrive in the public markets.

Whether you're a biotech founder, a BD lead, or a strategic investor, this session will offer actionable guidance on timing, readiness, and long-term positioning.

• Understand the legal and structural foundations biotech companies must have in place before even considering going public
• Explore how market conditions, investor expectations, and deal momentum influence IPO timing and valuation
• Learn how public market readiness affects partnership conversations with pharma, VCs, and strategic acquirers
• Examine case studies on what separates smooth IPOs from those that stall or backfire post-listing